PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock
Clinical trial NCT02820987 · COMPLETED
Trial details
- NCT number
- NCT02820987
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-27
- Primary completion
- 2018-10-04
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.